<DOC>
	<DOCNO>NCT01079715</DOCNO>
	<brief_summary>The purpose study determine whether administration propranolol effective treatment retinopathy prematurity .</brief_summary>
	<brief_title>Safety Efficacy Propranolol Newborns With Retinopathy Prematurity</brief_title>
	<detailed_description>Retinopathy Prematurity ( ROP ) still major cause blindness child develop country around world , increase cause blindness develop country . The ablation retina photocoagulation laser cryotherapy reduces incidence blindness suppress neovascular phase ROP . However , visual outcome treatment often poor . The development ROP depend largely vascular endothelial growth factor ( VEGF ) . The reduction VEGF expression neovascular phase might prevent destructive neovascularization ROP . The purpose study evaluate whether administration propranolol safe able reduce incidence blindness suppress neovascular phase ROP compare control group receive conventional laser therapy .</detailed_description>
	<mesh_term>Retinal Diseases</mesh_term>
	<mesh_term>Premature Birth</mesh_term>
	<mesh_term>Retinopathy Prematurity</mesh_term>
	<mesh_term>Propranolol</mesh_term>
	<mesh_term>Angiogenesis Modulating Agents</mesh_term>
	<criteria>1 . Infants screen ROP ( â‰¤ 32 week gestation ) develop Stage 2 ROP zone II without plus . 2 . Informed Consent parent 1 . Newborns one follow condition enrollment study : Heart failure . Recurrent episodes bradycardia ( Heart rate le 90 bpm ) . Atrioventricular block ( second third degree ) . Significant congenital heart anomaly , include patent ductus arteriosus , patent foramen ovale small ventricular septal defect . Hypotension . Renal failure . Cerebral hemorrhage . Other disease contraindicate use betablockers 2 . Newborns ROP stag advance Stage 2 zone II without plus . 3 . Informed Consent parent refuse . This mean infant automatically receive standard laser therapy . No data use infant without Informed Consent .</criteria>
	<gender>All</gender>
	<minimum_age>22 Weeks</minimum_age>
	<maximum_age>32 Weeks</maximum_age>
	<verification_date>November 2012</verification_date>
	<keyword>Newborn</keyword>
	<keyword>Retinal Diseases</keyword>
	<keyword>Angiogenesis Modulating Agents</keyword>
	<keyword>Adrenergic beta-Antagonists</keyword>
</DOC>